RGT — Argent BioPharma Share News
0.000.00%
- AU$3.56m
- AU$3.48m
- AU$0.16m
Brief: Argent Biopharma Seeks Trading Halt
June 2024 Quarter Activity Report and Cash Flow
Placing to Raise US$2,000,000
Brief: Argent Biopharma Says Placing To Raise $2 Million
Brief: Argent Biopharma Seeks Trading Halt
Placing to Raise US$500,000
Brief: Argent Biopharma Seeks Trading Halt
Brief: Argent Biopharma Names Igor Bluvstein As CFO
Trading on the OTCQB and Appointment of CFO
Brief: Argent Biopharma Ltd Says Ordinary Shares Approved To Trade On The Otcqb Venture Market In The United States
PDMR Notification
March 2024 Quarter Activity Report
Dr. Shlomo Sadoun Joins Advisory Board
PDMR Notification
MGC Pharmaceuticals - PDMR Notification
MGC Pharmaceuticals - Refinancing of Convertible Securities Agreement
Brief: MGC Pharmaceuticals Posts HY Net Loss Attributable A$7.1 Million Versus Loss A$10.9 Million
MGC Pharmaceuticals - December 2023 Quarter Activity Report
MGC Pharmaceuticals - Director/PDMR Shareholding